Galapagos NV
GLPG
#4557
Rank
S$2.84 B
Marketcap
S$42.76
Share price
-1.20%
Change (1 day)
19.73%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): S-$0.42

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is S-$0.43. In 2024 the company made an earnings per share (EPS) of S$1.48 a decrease over its 2023 EPS that were of S$4.49.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.42-128.75%
2024S$1.48-67.16%
2023S$4.49-199.64%
2022S-$4.5199.03%
2021S-$2.27-68.98%
2020S-$7.30-298.06%
2019S$3.69-554.64%
2018S-$0.81-77.18%
2017S-$3.56-326.21%
2016S$1.57-134.19%
2015S-$4.60-371.34%
2014S$1.69-445.98%
2013S-$0.4932.88%
2012S-$0.37-82.07%
2011S-$2.06-817.9%
2010S$0.2912.73%
2009S$0.25-120.79%
2008S-$1.22-37.67%
2007S-$1.9639.64%
2006S-$1.4028.17%
2005S-$1.096.25%
2004S-$1.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.10-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.75-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.03-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.61-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$9.25-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$6.77-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$4.77-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S-$0.77 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.57-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel